Dzulkefly: Low health literacy main reason for people avoiding regular health screenings
He said most people only seek treatment when the disease has been identified or is at a more serious stage, rather than go for an early check-up.
That is why, he said, it is important for the public to take care of their health and that of their family members by going for health screenings, followed by intervention and treatment.
'This is why the Ministry of Health (MOH), under the National Health Screening Initiative (NHSI), emphasises screening, not only for NCDs, but also for cancer and mental health,' he told reporters after opening the Paroi constituency's Healthy Mind Carnival, Prosperous Community here today.
Also present was Negeri Sembilan Health Director Dr Zuraida Mohamed.
Citing the latest National Health and Morbidity Survey (NHMS), Dzulkefly said that one in three adult Malaysians suffers from high blood pressure, one in three has high cholesterol, while one in six suffers from diabetes, with 50 per cent facing obesity.
'That is why I want to see greater awareness about the importance of health screenings. I hope these efforts are well-received by the people. We have initiatives like Peka B40, Komuniti Sihat Pembina Negara (KOSPEN) and services at District Health Offices,' he said.
Meanwhile, he said COVID-19 cases in the country are under control and below the national alert level, with an average of 600 cases per week.
The Health Ministry, he said, will continue to monitor the situation.
When asked about the need for Malaysians to get an additional dose of the COVID-19 vaccine following the increase in cases in a neighbouring country, he said there was no need to make it mandatory at this time, but advised the public to always take preventive measures. — BERNAMA
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Malay Mail
8 hours ago
- Malay Mail
Drug price transparency kicks in at private clinics and pharmacies, full enforcement by January 2026
KUALA LUMPUR, Aug 3 — The Ministry of Health (MOH) and the Ministry of Domestic Trade and Cost of Living (KPDN) are implementing the drug price display initiative at private health facilities and community pharmacies in stages starting August 1. According to a joint statement by both ministries, the initiative, which was implemented under the Price Control and Anti-Profiteering (Price Marking of Medicines) Order 2025 [P.U.(A) 141/2025] under the Price Control and Anti-Profiteering Act 2011, began on May 1. The statement said the educational enforcement approach was implemented in the first three months ending July 31. 'During the period, 842 facilities consisting of medical clinics, dental clinics and private hospitals as well as community pharmacies were inspected and the majority of them have implemented this initiative with 57 per cent of them complying with the requirements for satisfactory drug price display,' according to the statement. In this regard, enforcement will continue in stages from August 1 through educational approach inspections and advocacy for two months until September 30 and a reminder letter may be issued in the event of non-compliance. According to the statement, starting October 1, compounds would be issued for repeat offences before full enforcement on January 1, 2026. MOH and KPDN also took note of the judicial review action filed in the High Court by seven organisations representing medical and dental practitioners and one private medical practitioner regarding the validity of Order PU (A) 141/2025. 'However, until this statement is issued, there is no court order directing the suspension of the implementation or enforcement of this order. Therefore, Order P.U.(A) 141/2025 remains valid and in force,' according to the statement. MOH and KPDN also expressed their commitment to implement the initiative in an inclusive, phased and prudent manner to ensure that its benefits are enjoyed by consumers and contribute to increasing transparency, accountability and trust in the country's health system. — Bernama
The Star
9 hours ago
- The Star
Health Ministry ordered to refine proposal to review private GP fees, Dewan Rakyat told
PETALING JAYA: The Health Ministry has been instructed to fine-tune its proposal to review consultation fees for private general practitioners (GPs) and to continue discussions with stakeholders, as per the Dewan Rakyat. In a parliamentary written reply dated July 31, Health Minister Datuk Seri Dr Dzulkefly Ahmad stated that the Cabinet had been presented with a review of consultation fees for private GPs. "However, the Health Ministry was directed to refine its proposal and continue engagement sessions with stakeholders and interested parties," he said. Dr Dzulkefly noted that consultation fees for private GPs fall under the Private Healthcare Facilities and Services Act 1998 (Act 586). He was responding to Tan Kar Hing (PH-Gopeng), who inquired whether the medicine price display rule would consider the realities faced by private medical practitioners. Tan also asked if the Health Ministry would consider a more balanced approach beyond the Price Control Act, and whether it could review the consultation fees for private GPs, which have remained unchanged since 1992. On March 13, Dr Dzulkefly announced that revised consultation fees for GPs would be disclosed before May 1. On June 9, he mentioned that a review of consultation fees had been raised with a task force chaired by Deputy Prime Minister Datuk Seri Ahmad Zahid Hamidi. The Medical Practitioners Coalition Association of Malaysia (MPCAM) has proposed increasing private GP fees to between RM50 and RM80. MPCAM highlighted that GP consultation fees have remained at RM10 to RM35 for over three decades since 1992.
The Sun
9 hours ago
- The Sun
Drug price display initiative continues in Malaysia from Aug 1
KUALA LUMPUR: The Ministry of Health (MOH) and the Ministry of Domestic Trade and Cost of Living (KPDN) are proceeding with the drug price display initiative at private healthcare facilities and community pharmacies. The phased implementation, which began on August 1, follows an initial educational enforcement period from May 1 to July 31. A joint statement from both ministries confirmed that 842 facilities, including medical clinics, dental clinics, private hospitals, and community pharmacies, were inspected during the initial phase. Of these, 57 per cent complied with the drug price display requirements. 'Enforcement will continue through inspections and advocacy until September 30, with reminder letters issued for non-compliance,' the statement said. Full enforcement, including penalties for repeat offences, will begin on January 1, 2026. The ministries acknowledged a judicial review filed by seven medical and dental organisations challenging the validity of the Price Control and Anti-Profiteering (Price Marking of Medicines) Order 2025. However, they clarified that no court order has suspended the initiative, meaning the regulation remains in effect. MOH and KPDN reiterated their commitment to implementing the policy in a structured manner to enhance transparency and consumer trust in Malaysia's healthcare system. - Bernama
